Literature DB >> 18953350

Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis.

Manuel A Friese1, Karen B Jakobsen, Lone Friis, Ruth Etzensperger, Matthew J Craner, Róisín M McMahon, Lise T Jensen, Véronique Huygelen, E Yvonne Jones, John I Bell, Lars Fugger.   

Abstract

The major known genetic risk factors in multiple sclerosis reside in the major histocompatibility complex (MHC) region. Although there is strong evidence implicating MHC class II alleles and CD4(+) T cells in multiple sclerosis pathogenesis, possible contributions from MHC class I genes and CD8(+) T cells are controversial. We have generated humanized mice expressing the multiple sclerosis-associated MHC class I alleles HLA-A(*)0301 (encoding human leukocyte antigen-A3 (HLA-A3)) and HLA-A(*)0201 (encoding HLA-A2) and a myelin-specific autoreactive T cell receptor (TCR) derived from a CD8(+) T cell clone from an individual with multiple sclerosis to study mechanisms of disease susceptibility. We demonstrate roles for HLA-A3-restricted CD8(+) T cells in induction of multiple sclerosis-like disease and for CD4(+) T cells in its progression, and we also define a possible mechanism for HLA-A(*)0201-mediated protection. To our knowledge, these data provide the first direct evidence incriminating MHC class I genes and CD8(+) T cells in the pathogenesis of human multiple sclerosis and reveal a network of MHC interactions that shape the risk of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18953350     DOI: 10.1038/nm.1881

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  82 in total

Review 1.  [The genetic profile of multiple sclerosis: risk genes and the "dark matter"].

Authors:  C M Lill; F Zipp
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

Review 2.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

3.  Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers.

Authors:  Tongguang Wang; Myoung-Hwa Lee; Tory Johnson; Rameeza Allie; Lina Hu; Peter A Calabresi; Avindra Nath
Journal:  J Neurosci       Date:  2010-04-07       Impact factor: 6.167

Review 4.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

5.  A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.

Authors:  Alessandro Didonna; Noriko Isobe; Stacy J Caillier; Kathy H Li; Alma L Burlingame; Stephen L Hauser; Sergio E Baranzini; Nikolaos A Patsopoulos; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2015-10-03       Impact factor: 6.150

6.  A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells.

Authors:  Ana C Anderson; Rucha Chandwaskar; David H Lee; Jenna M Sullivan; Adam Solomon; Roselynn Rodriguez-Manzanet; Bernhard Greve; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

Review 7.  Lifestyle and Environmental Factors in Multiple Sclerosis.

Authors:  Lars Alfredsson; Tomas Olsson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 8.  Genetic determinants of risk and progression in multiple sclerosis.

Authors:  Alessandro Didonna; Jorge R Oksenberg
Journal:  Clin Chim Acta       Date:  2015-02-04       Impact factor: 3.786

9.  T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy.

Authors:  Elaine M Sloand; J Joseph Melenhorst; Zachary C G Tucker; Loretta Pfannes; Jason M Brenchley; Agnes Yong; Valeria Visconte; Colin Wu; Emma Gostick; Phillip Scheinberg; Matthew J Olnes; Daniel C Douek; David A Price; A John Barrett; Neal S Young
Journal:  Blood       Date:  2010-11-19       Impact factor: 22.113

Review 10.  Autoimmune T cell responses in the central nervous system.

Authors:  Joan Goverman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.